CURRENT ISSUE Current Issue Cover
VOL 8 • NO 7 NOV/DEC 2017
IN THIS ISSUE

Innovations in Cancer Therapies and Rising Costs

Pamela Hallquist Viale, RN, MS, CNS, ANP



Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies

Ali McBride,(1) PharmD, MS, BCPS, BCOP, Steven Trifilio,(2) RPh, Nadine Baxter,(3) MNSc, APN-BC, AOCNP®, Tara K. Gregory,(4) MD, and Scott C. Howard,(5) MD, MS

 
Section Seperator

TODAY'S NEWS

ASH 2017: Low–Molecular-Weight He...

Results suggest the direct oral anticoagulant edox...

ASH 2017: HERCULES Trial: Caplacizumab S...

In a phase III trial, patients with acquired throm...

ASH 2017: Abatacept Nearly Eliminates Se...

Results from a phase II clinical trial presented b...

Hormonal Contraception and Breast Cancer...

As reported in The New England Journal of Medicine...

Prognostic Factors in Stage III Favorabl...

An analysis from the Children’s Oncology Gro...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Lenalidomide-Associated Cytopenias in MDS

A male patient aged 67 years with a 2-year history of refractory anemia and myelodysplastic syndromes..

Anaplastic Lymphoma Kinase Inhibitors for NSCLC

Lung cancer is the second most commonly diagnosed cancer in the U.S., with an estimated 222,500 new cases in 2017...

Li-Fraumeni Syndrome

Li-Fraumeni syndrome is a rare inherited autosomal-dominant disorder that is manifested by a wide range of malignancies that appear at an unusually early age...

Immunotherapy Through the Years

Immunotherapy’s use in oncology has emerged in recent years as an important treatment option in many different disease sites...

Lenvatinib for Thyroid Cancer and Advanced RCC

Differentiated thyroid cancer (DTC) is a malignancy that is occurring with greater frequency...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Number of Metastatic Lymph Nodes and Sur...

A study using National Cancer Database data has sh...

ASH 2017: MURANO Trial: Venetoclax Found...

In the phase III MURANO trial, treatment with the ...

ASH 2017: ALCYONE Trial: Adding Daratumu...

The first randomized trial to evaluate the use of ...

ASH 2017: People Aged 75 Years and Older...

In the first comprehensive analysis of clinical tr...

BELLE-3 Trial: Combination Therapy in Re...

The phase III BELLE-3 trial has shown prolonged pr...

More Highlights More Highlights
Section Seperator

LATEST TWEETS







More Tweets More Tweets
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here